CARE Ratings
1,437.00
+24.50(+1.73%)
Market Cap₹4,314.60 Cr
PE Ratio25.94
Company Performance:
1D+1.73%
1M-9.35%
6M-7.45%
1Y+25.09%
5Y+227.33%
View Company Insightsright
More news about CARE Ratings
18Feb 26
CARE Ratings receives cautionary letter from BSE and NSE for incorrect ISIN reporting in credit rating disclosure
CARE Ratings Limited received cautionary letters from BSE and NSE on February 17, 2026, for inadvertently reporting incorrect ISIN of a client in credit rating disclosure on System Driven Disclosure platform. The exchanges advised the company to exercise due caution in future disclosures. CARE Ratings has confirmed that this regulatory communication has no impact on its financial, operational, or other business activities.
 no imag found
11Feb 26
CARE Ratings Limited Reports Strong Q3 FY26 Results with 15% Revenue Growth
CARE Ratings Limited reported strong Q3 FY26 results with standalone revenue growing 15% YoY to Rs. 90.24 crores and consolidated revenue up 16% to Rs. 112.12 crores. For 9M FY26, standalone revenue reached Rs. 280.15 crores (14% growth) while consolidated revenue stood at Rs. 342.40 crores (17% growth). The ratings segment contributed 89% of revenue with Rs. 305.69 crores, growing 17% YoY, while maintaining healthy EBITDA margins of 46% for standalone operations.
 no imag found
20Jan 26
CARE Ratings Limited Announces Changes in Board Committee Composition
CARE Ratings Limited announced changes in Board Committee composition effective immediately following a January 20, 2026 Board meeting. The restructuring affects three key committees with new leadership appointments: Mr. Manoj Chugh leads the Nomination and Remuneration Committee, Ms. Indrani Banerjee chairs the Stakeholders Relationship Committee, and Mr. Rajiv Bansal heads the Strategy and Investment Committee. The changes demonstrate the company's commitment to enhanced governance effectiveness and regulatory compliance.
 no imag found
16Jan 26
CARE Ratings Completes Postal Ballot: Dr. Bimal Patel Appointed Independent Director
CARE Ratings Limited successfully concluded its postal ballot process with overwhelming shareholder support of 99.99% for appointing Dr. Bimal Patel as Non-Executive Independent Director for a three-year term. The voting involved 13.13 million shares from 408 shareholders, with scrutinizer Mitesh Dhabliwala confirming the process validity and the company completing all regulatory filings with stock exchanges.
 no imag found
08Nov 25
CARE Ratings Expands Employee Stock Ownership with New Allotment and ESOP Grant
CARE Ratings has allotted 6,283 equity shares to employees under its ESOP scheme, increasing its paid-up share capital from Rs. 30,00,70,800 to Rs. 30,01,33,630. The company also approved a new grant of 27,000 stock options at an exercise price of Rs. 1,567 per share, vesting over three years. This move aims to enhance employee engagement and align interests with shareholders.
 no imag found
05Aug 25
CARE Ratings Unveils Growth Strategy Amid Robust Q1 Performance
CARE Ratings Limited reported robust Q1 financial results with consolidated revenue growing 19% YoY to ₹93.91 crore. The company's EBITDA increased by 28% to ₹27.80 crore, while net profit rose 24% to ₹26.50 crore. The ratings business showed 18% YoY growth, contributing significantly to overall performance. CARE Ratings announced plans to expand key business areas, enhance geographical reach, and improve competitiveness. The company remains optimistic about growth opportunities despite global economic uncertainties, citing strong fundraising activities and positive economic indicators in India.
 no imag found
05Aug 25
CARE Ratings Posts 24% Profit Growth in Q1, Reappoints Two Independent Directors
CARE Ratings Limited reported a 24% year-on-year increase in consolidated net profit to ₹2,649.74 lakhs for Q1 FY2024. Consolidated revenue from operations grew 19% to ₹9,390.50 lakhs. The ratings segment revenue increased by 18%, while other segments saw 30% growth. The company reappointed two independent directors, Mr. G. Mahalingam and Mr. V. Chandrasekaran, for three-year terms. CARE Ratings also granted 7,500 stock options to employees and allotted 25,933 equity shares under its ESOS 2020.
 no imag found
05Aug 25
CARE Ratings Reports 24% Jump in Q1 Net Profit, Board Approves Director Reappointments
CARE Ratings Limited announced robust Q1 FY26 results, with consolidated net profit up 24% to ₹2,649.74 lakhs and revenue rising 19% to ₹9,390.50 lakhs. EPS improved to ₹8.61. The ratings business segment grew 18%, while non-ratings revenue increased by 30%. The company reappointed two Independent Directors and granted employee stock options. Management noted a positive start to FY26 despite global economic challenges.
 no imag found
02Jul 25
SAT Overturns Sebi's Two-Year Ban on Former Care Ratings MD
The Securities Appellate Tribunal (SAT) has quashed a two-year ban imposed by Sebi on Rajesh Mokashi, former Managing Director of CARE Ratings. SAT criticized Sebi's action as a 'misadventure' and ordered the regulator to pay ₹5 lakh to Mokashi for appeal costs. The ban was related to alleged credit rating manipulation. This ruling could potentially impact CARE Ratings' reputation positively and highlights the importance of checks and balances in India's financial regulatory system.
 no imag found
13May 25
CARE Ratings Posts Impressive Q4 Results: PAT Surges 29%, Stock Soars 15%
CARE Ratings, an Indian credit rating agency, reported a 29% year-over-year increase in Q4 PAT to Rs 44.90 crore. Q4 revenue grew by 22% to Rs 91.20 crore. EBITDA increased by 31% with a 50.00% margin. The company announced a final dividend of Rs 11.00 per share. For the full fiscal year 2025, PAT rose 24% to Rs 147.90 crore with a 19% revenue growth. The stock price surged 15% in response to these results.
 no imag found
12May 25
CARE Ratings: Q4 Profit Surges 76%, ₹11 Dividend Declared
CARE Ratings announced strong Q4 FY25 results with a 76.40% increase in net profit to ₹43.40 crore. Revenue grew by 21.90% to ₹109.70 crore, while EBITDA rose 64.80% to ₹47.70 crore with a 43.20% margin. The company declared a final dividend of ₹11.00 per share and reported its highest-ever annual income from operations for FY25.
 no imag found
CARE Ratings
1,437.00
+24.50
(+1.73%)
1 Year Returns:+25.09%
Industry Peers
CRISIL
3,951.30
(-1.20%)
ICRA
5,118.00
(-0.33%)
CARE Ratings
1,437.00
(+1.73%)